EW Q2 2017 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$842M+10.9% YoY

Gross Profit

$633M75.2% margin

Operating Income

$255M30.3% margin

Net Income

$186M22.1% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

$198M

Free Cash Flow

$136M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$5.1B

Total Liabilities

$2.2B

Stockholders' Equity

$2.9B

Cash & Equivalents

$508M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$842M	$759M	+10.9%
Gross Profit	$633M	$557M	+13.7%
Operating Income	$255M	$181M	+41.1%
Net Income	$186M	$127M	+47.0%

Revenue Segments

Transcatheter Heart Valves

$488M58%

Surgical Heart Valve Therapy

$207M25%

Critical Care

$147M17%

Geographic Segments

UNITED STATES

$479M57%

Europe

$184M22%

JAPAN

$91M11%

Rest of World

$89M11%